Karabay, C. Y. Et Al. 2013. Drospirenone-containing oral contraceptives and risk of adverse outcomes after myocardial infarction. Catheterization and Cardiovascular Interventions , vol.82, no.3 , 387-393.

Karabay, C. Y., Kocabay, G., Oduncu, V., Kalayci, A., Guler, A., Karagöz, A., ... Candan, Ö.(2013). Drospirenone-containing oral contraceptives and risk of adverse outcomes after myocardial infarction. Catheterization and Cardiovascular Interventions , vol.82, no.3, 387-393.

Karabay, Can Et Al. "Drospirenone-containing oral contraceptives and risk of adverse outcomes after myocardial infarction," Catheterization and Cardiovascular Interventions , vol.82, no.3, 387-393, 2013

Karabay, Can Y. Et Al. "Drospirenone-containing oral contraceptives and risk of adverse outcomes after myocardial infarction." Catheterization and Cardiovascular Interventions , vol.82, no.3, pp.387-393, 2013

Karabay, C. Y. Et Al. (2013) . "Drospirenone-containing oral contraceptives and risk of adverse outcomes after myocardial infarction." Catheterization and Cardiovascular Interventions , vol.82, no.3, pp.387-393.

@article{article, author={Can Yucel Karabay Et Al. }, title={Drospirenone-containing oral contraceptives and risk of adverse outcomes after myocardial infarction}, journal={Catheterization and Cardiovascular Interventions}, year=2013, pages={387-393} }